A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor

N Ratner, SJ Miller - Nature Reviews Cancer, 2015 - nature.com
Abstract Neurofibromatosis type 1 (NF1) is a common genetic disorder that predisposes
affected individuals to tumours. The NF1 gene encodes a RAS GTPase-activating protein …

[HTML][HTML] The role of the ALK receptor in cancer biology

B Hallberg, RH Palmer - Annals of Oncology, 2016 - Elsevier
ABSTRACT A vast array of oncogenic variants has been identified for anaplastic lymphoma
kinase (ALK). Therefore, there is a need to better understand the role of ALK in cancer …

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

B Hallberg, RH Palmer - Nature Reviews Cancer, 2013 - nature.com
The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many
cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer …

Malignant peripheral nerve sheath tumor: models, biology, and translation

BN Somatilaka, A Sadek, RM McKay, LQ Le - Oncogene, 2022 - nature.com
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive, invasive cancer that
comprise around 10% of all soft tissue sarcomas and develop in about 8–13% of patients …

Gamma neurons mediate dopaminergic input during aversive olfactory memory formation in Drosophila

H Qin, M Cressy, W Li, JS Coravos, SA Izzi, J Dubnau - Current biology, 2012 - cell.com
Mushroom body (MB)-dependent olfactory learning in Drosophila provides a powerful model
to investigate memory mechanisms. MBs integrate olfactory conditioned stimulus (CS) inputs …

Neurofibromin and suppression of tumorigenesis: beyond the GAP

J Mo, SL Moye, RM McKay, LQ Le - Oncogene, 2022 - nature.com
Abstract Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disease and one
of the most common inherited tumor predisposition syndromes, affecting 1 in 3000 …

Emerging therapeutic targets for neurofibromatosis type 1

JA Walker, M Upadhyaya - Expert opinion on therapeutic targets, 2018 - Taylor & Francis
ABSTRACT Introduction: Neurofibromatosis type 1 (NF1) is an autosomal dominantly
inherited tumor predisposition syndrome with an incidence of one in 3000–4000 individuals …

Tumor resistance against ALK targeted therapy-where it comes from and where it goes

GG Sharma, I Mota, L Mologni, E Patrucco… - Cancers, 2018 - mdpi.com
Anaplastic lymphoma kinase (ALK) is a validated molecular target in several ALK-
rearranged malignancies, particularly in non-small-cell lung cancer (NSCLC), which has …

[HTML][HTML] Modelling learning and memory in Drosophila to understand intellectual disabilities

V Mariano, T Achsel, C Bagni, AK Kanellopoulos - Neuroscience, 2020 - Elsevier
Neurodevelopmental disorders (NDDs) include a large number of conditions such as Fragile
X syndrome, autism spectrum disorders and Down syndrome, among others. They are …

The therapeutic potential of neurofibromin signaling pathways and binding partners

J Báez-Flores, M Rodríguez-Martín, J Lacal - Communications Biology, 2023 - nature.com
Neurofibromin controls many cell processes, such as growth, learning, and memory. If
neurofibromin is not working properly, it can lead to health problems, including issues with …